Search Within

Phuong Hong Dao

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
  3. Research Letter (1)
Groups
  1. Clinical Pharmacy Specialists (8)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Lymphoma (7)
  6. Survivorship Research (5)

More Groups

People
  1. Michael Buege (7)
  2. Terry Pak (7)
  3. Andrea Levoir (6)
  4. Esther Drill (4)
  5. Matthew Matasar (4)
  6. Steven Horwitz (4)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (1)
Publications
  1. Blood (2)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)
  3. European Journal of Haematology (1)
  4. Haematologica (1)
  5. Hematological Oncology (1)
  6. Journal of Oncology Pharmacy Practice (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. Elsevier Inc. (1)
  3. Ferrata Storti Foundation (1)
  4. John Wiley & Sons (1)
  5. Sage Publications Ltd. (1)
  6. Taylor & Francis Group (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure
    Journal Article

    Buege, M. J.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Dao, P. H.; Matasar, M. J.
    European Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: A single-center experience
    Journal Article

    Pak, T. K.; Dixon, B. N.; Buege, M. J.; Dao, P. H.; Leary, M. H.; Jarrett, J. C.; Duggan, T. A.; Caron, P.; Falchi, L.; Hamlin, P.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save